腭成形术的主要目标是恢复正常的言语,可以瞄准,在许多程序中,通过推回技术延长腭;它的并发症之一是上颌生长异常。许多人认为影响CLP患者面部生长的主要因素是pal成形术,这是由于某些手术技术导致的大量疤痕回缩。非交联双层生物可吸收胶原基质Mucograft™(GeistlichPharmaAG,Wolhusen,瑞士)是在第二意图愈合情况下帮助伤口闭合的潜在工具。
这项工作的目的是测试无细胞真皮基质(Mucograft®)在Veau-Wardill-Kilner腭成形术的实验模型中的使用,作为减少剥脱腭粘膜疤痕回缩的工具。
使用24只3周龄雄性Wistar大鼠。将动物随机分为两组。在对照组中,切除了腭骨暴露,模拟Veau-Wardill-Kilner腭成形术中留下的缺损。在干预组中,执行了相同的程序,用生物可吸收的胶原基质(Mucograft®)处理剥脱的腭骨区域。对于数据收集,术后9周(生命12周),通过过量的麻醉剂量使动物安乐死。上颌生长,疤痕的宏观外观,疼痛,和出血进行了评估。
上颚长度生长组间有显著统计学差异(7.6mm+-0.38mmvs5.5mm+-0.36mm,P=.009)和腭宽生长(1.47mm+-0.8mmvs-0.09mm+-0.55mm,P=.001),与对照组相比,有利于真皮基质组。而疼痛和出血,两组间无差异.
在腭上具有骨剥脱区域的大鼠中使用真皮基质增加上颌长度和宽度生长模式。此外,它不会增加疼痛,出血,或术后并发症。
The primary goal of palatoplasty is the restoration of normal speech, that can be aimed by, among many procedures, lengthening the palate through the pushback technique; one of its complications is abnormal maxillary growth. The main factor affecting facial growth in CLP patients is believed by many to be the palatoplasty-due to the large scar retraction resulting from some surgical techniques. The non-crosslinked two-layer bioabsorbable collagen matrix Mucograft™ (Geistlich Pharma AG, Wolhusen, Switzerland) is a potential tool to aid in wound closure in a second-intention healing situation.
The objective of this work was to test the use of an acellular dermal matrix (Mucograft®) in an experimental model of Veau-Wardill-Kilner palatoplasty, as a tool to reduce scar retraction of the denuded palatine mucosa.
Twenty-four 3-week-old male Wistar rats were used. The animals were randomly divided into two groups. In the control group, an excision was made with bone exposure in the palate, simulating the defect left in the Veau-Wardill-Kilner palatoplasty. In the intervention group, the same procedure was performed, and the area of denuded palatine bone was treated with a bioabsorbable collagen matrix (Mucograft®). For data collection, 9 weeks after surgery (12 weeks of life), the animals were euthanized by excessive anesthetic dosage. Maxillary growth, macroscopic appearance of the scar, pain, and bleeding were evaluated.
There were significant statistical differences between the groups for palate length growth (7.6 mm + -0.38 mm vs 5.5 mm + -0.36 mm, P = .009) and for palate width growth (1.47 mm + -0.8 mm vs -0.09 mm + -0.55 mm, P = .001), favoring dermal matrix group compared to controls. Whereas for pain and bleeding, there were no differences between the groups.
The use of dermal matrix in rats with an area of bone denudation on the palate increases maxillary length and width growth patterns. Besides, it does not increase pain, bleeding, or post-operative complications.